![](/img/cover-not-exists.png)
896 The NFKB inhibitor sulfasalazine enhances recovery from CCL4 induced fibrosis: therapeutic implications
Derek A. Mann, Fiona Oakley, Caralyn Marek, Murial Meso, Harry Millward-Sadler, Matthew WrightVolume:
38
Year:
2003
Language:
english
DOI:
10.1016/s0270-9139(03)80937-0
File:
PDF, 131 KB
english, 2003